| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44920 | |||
| Azide and BSA Free | NBP2-34593-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-23442-25ug | |||
| BSA Free | NBP3-23442-100ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-64849SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-37328-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75902SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52661-0.025mg | |||
![Flow Cytometry: CD3 epsilon Antibody (APA1/1) [NBP1-30426] - Intracellular staining of JURKAT cells with anti-CD3 epsilon activation epitope (APA1/1) PE.](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-APA1-1-Flow-Cytometry-NBP1-30426-img0002.jpg "Flow Cytometry: CD3 epsilon Antibody (APA1/1) [NBP1-30426] - Intracellular staining of JURKAT cells with anti-CD3 epsilon activation epitope (APA1/1) PE.")
![Flow Cytometry: CD3 epsilon Antibody (APA1/1) [NBP1-30426] - Intracellular staining of human peripheral blood with anti-CD3 epsilon activation epitope (APA1/1) purified, GAM-FITC.](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-APA1-1-Flow-Cytometry-NBP1-30426-img0001.jpg)
![Western Blot: CD27/TNFRSF7 Antibody (JB40-98) [NBP2-75434] - Analysis of CD27 on Raji cell using anti-CD27 antibody at 1/500 dilution.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-JB40-98-Western-Blot-NBP2-75434-img0005.jpg "Western Blot: CD27/TNFRSF7 Antibody (JB40-98) [NBP2-75434] - Analysis of CD27 on Raji cell using anti-CD27 antibody at 1/500 dilution.")
![Immunocytochemistry/Immunofluorescence: CD27/TNFRSF7 Antibody (JB40-98) [NBP2-75434] - Staining CD27 in K562 cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-JB40-98-Immunocytochemistry-Immunofluorescence-NBP2-75434-img0002.jpg)
![Immunohistochemistry-Paraffin: CD27/TNFRSF7 Antibody (JB40-98) [NBP2-75434] - Analysis of paraffin-embedded rat spleen tissue using anti-CD27 antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-JB40-98-Immunohistochemistry-Paraffin-NBP2-75434-img0004.jpg)
![Flow Cytometry: CD27/TNFRSF7 Antibody (JB40-98) [NBP2-75434] - Analysis of Daudi cells with CD27 antibody at 1/100 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black). Alexa Fluor 488-conjugated goat anti rabbit IgG was used as the secondary antibody.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-JB40-98-Flow-Cytometry-NBP2-75434-img0001.jpg)
![Immunohistochemistry-Paraffin: CD27/TNFRSF7 Antibody (JB40-98) [NBP2-75434] - Analysis of paraffin-embedded human tonsil tissue using anti-CD27 antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-JB40-98-Immunohistochemistry-Paraffin-NBP2-75434-img0003.jpg)
![Immunohistochemistry-Paraffin: CD5 Antibody (CD5/54/F6) [NBP2-32824] - Formalin-fixed, paraffin-embedded human tonsil stained with CD5 MAb (CD5/54/F6)](http://images.novusbio.com/fullsize/CD5-Antibody-CD5-54-F6-Immunohistochemistry-Paraffin-NBP2-32824-img0001.jpg "Immunohistochemistry-Paraffin: CD5 Antibody (CD5/54/F6) [NBP2-32824] - Formalin-fixed, paraffin-embedded human tonsil stained with CD5 MAb (CD5/54/F6)")
![Flow Cytometry: CD5 Antibody (CD5/54/F6) [NBP2-32824] - T cell characterization in canine whole blood cells. From a verified customer review. Image using the Alexa Fluor 700 format of this antibody.](http://images.novusbio.com/fullsize/CD5-Antibody-CD5-54-F6-Flow-Cytometry-NBP2-32824-img0003.jpg)
![Western Blot: TCIRG1 Antibody (6H3) [H00010312-M01] - Detection against Immunogen (36.74 KDa) .](http://images.novusbio.com/fullsize/TCIRG1-Antibody-6H3-Western-Blot-H00010312-M01-img0001.jpg "Western Blot: TCIRG1 Antibody (6H3) [H00010312-M01] - Detection against Immunogen (36.74 KDa) .")
![Western Blot: LAT Antibody (LAT.10-17) [NBP2-00289] - 10e6 normal peripheral human blood cells (lane 1), Jurkat (lane 2), and C57BL/6 splenocytes (lane 3) with 5 ug/mL Anti-Human LAT Purified. Bands were visualized using Anti-Mouse IgG HRP.](http://images.novusbio.com/fullsize/LAT-Antibody-LAT-10-17-Western-Blot-NBP2-00289-img0001.jpg "Western Blot: LAT Antibody (LAT.10-17) [NBP2-00289] - 10e6 normal peripheral human blood cells (lane 1), Jurkat (lane 2), and C57BL/6 splenocytes (lane 3) with 5 ug/mL Anti-Human LAT Purified. Bands were visualized using Anti-Mouse IgG HRP.")
![Immunohistochemistry-Paraffin: LAT Antibody (LAT.10-17) [NBP2-00289] - Staining of human thymus. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 20 ug/ml.](http://images.novusbio.com/fullsize/LAT-Antibody-LAT-10-17-Immunohistochemistry-Paraffin-NBP2-00289-img0006.jpg)
![Flow (Cell Surface): LAT Antibody (LAT.10-17) [NBP2-00289] - Analysis using the Allophycocyanin conjugate of NBP2-00289. Surface staining of normal human peripheral blood cells with Anti-Human CD3 FITC followed by intracellular staining with Mouse IgG1 kappa Isotype Control APC (left) or Anti-Human LAT APC (right).](http://images.novusbio.com/fullsize/LAT-Antibody-LAT-10-17-Flow-Cell-Surface-NBP2-00289-img0008.jpg)
![Immunohistochemistry-Paraffin: LAT Antibody (LAT.10-17) [NBP2-00289] - Staining of human tonsil. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 20 ug/ml.](http://images.novusbio.com/fullsize/LAT-Antibody-LAT-10-17-Immunohistochemistry-Paraffin-NBP2-00289-img0005.jpg)
![ELISA: CTLA-4 Antibody (BNI3) [NB100-64849] - Human Anti-Abatacept Antibody bridging ELISA for Pharmacokinetic (PK) assay development A microtiter plate was coated overnight with Mouse Anti-Human CD152 Antibody, clone BNI3 at a concentration of 1 µg/ml. After washing and blocking with PBST + 5% BSA, 10% human serum was added spiked with increasing concentrations of abatacept. Detection was performed using HRP conjugated Human Anti-Abatacept Antibody, clone AbD37058ia at a concentration of 2 µg/ml in HISPEC Assay Diluent followed by QuantaBlu Fluorogenic Peroxidase Substrate. Data are shown as the mean of three measurements. HRP conjugation of the antibody used in this assay was performed using a LYNX Rapid HRP Antibody Conjugation Kit.](http://images.novusbio.com/fullsize/nb100-64849_mouse-monoclonal-ctla-4-antibody-bni3-2312025235988.jpg "ELISA: CTLA-4 Antibody (BNI3) [NB100-64849] - Human Anti-Abatacept Antibody bridging ELISA for Pharmacokinetic (PK) assay development A microtiter plate was coated overnight with Mouse Anti-Human CD152 Antibody, clone BNI3 at a concentration of 1 µg/ml. After washing and blocking with PBST + 5% BSA, 10% human serum was added spiked with increasing concentrations of abatacept. Detection was performed using HRP conjugated Human Anti-Abatacept Antibody, clone AbD37058ia at a concentration of 2 µg/ml in HISPEC Assay Diluent followed by QuantaBlu Fluorogenic Peroxidase Substrate. Data are shown as the mean of three measurements. HRP conjugation of the antibody used in this assay was performed using a LYNX Rapid HRP Antibody Conjugation Kit.")
![Western Blot: BLNK Antibody [NB100-804] - Staining of Daudi cell lysate (35 ug protein in RIPA buffer). Antibody at 0.3 ug/mL. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/BLNK-Antibody-Western-Blot-NB100-804-img0001.jpg "Western Blot: BLNK Antibody [NB100-804] - Staining of Daudi cell lysate (35 ug protein in RIPA buffer). Antibody at 0.3 ug/mL. Detected by chemiluminescence.")
![Immunocytochemistry/Immunofluorescence: BLNK Antibody [NB100-804] - Immunofluorescence analysis of paraformaldehyde fixed HepG2 cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL), showing some membrane staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL).](http://images.novusbio.com/fullsize/BLNK-Antibody-Immunocytochemistry-Immunofluorescence-NB100-804-img0002.jpg)
![Flow Cytometry: BLNK Antibody [NB100-804] - Flow cytometric analysis of paraformaldehyde fixed Daudi cells (blue line), permeabilized with 0.5% Triton. Primary incubation 1hr (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (1 ug/mL). IgG control: Unimmunized goat IgG (black line) followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/BLNK-Antibody-Flow-Cytometry-NB100-804-img0003.jpg)
![Western Blot: Siglec-2/CD22 Antibody (1A3A11) [NBP2-37328] - Western blot analysis using CD22 mAb against HEK293 (1) and CD22 (AA: 621-725)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-1A3A11-Western-Blot-NBP2-37328-img0003.jpg "Western Blot: Siglec-2/CD22 Antibody (1A3A11) [NBP2-37328] - Western blot analysis using CD22 mAb against HEK293 (1) and CD22 (AA: 621-725)-hIgGFc transfected HEK293 (2) cell lysate.")
![Immunocytochemistry/Immunofluorescence: Siglec-2/CD22 Antibody (1A3A11) [NBP2-37328] - Immunofluorescence analysis of Hela cells using CD22 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-1A3A11-Immunocytochemistry-Immunofluorescence-NBP2-37328-img0004.jpg)
![Flow Cytometry: Siglec-2/CD22 Antibody (1A3A11) [NBP2-37328] - Flow cytometric analysis of Hela cells using CD22 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-1A3A11-Flow-Cytometry-NBP2-37328-img0005.jpg)
![Western Blot: Siglec-2/CD22 Antibody (1A3A11) [NBP2-37328] - Western blot analysis using CD22 mAb against human CD22 recombinant protein. (Expected MW is 37 kDa)](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-1A3A11-Western-Blot-NBP2-37328-img0002.jpg)
![ELISA: Siglec-2/CD22 Antibody (1A3A11) [NBP2-37328] - Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng);](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-1A3A11-ELISA-NBP2-37328-img0001.jpg)
![Western Blot: CD38 Antibody (6E12D) [NBP1-47462] - Detection of CD38 in three non-small cell lung cancer cell lines. Western blot image submitted by a verified customer review.](http://images.novusbio.com/fullsize/CD38-Antibody-6E12D-Western-Blot-NBP1-47462-img0007.jpg "Western Blot: CD38 Antibody (6E12D) [NBP1-47462] - Detection of CD38 in three non-small cell lung cancer cell lines. Western blot image submitted by a verified customer review.")
![Immunohistochemistry-Paraffin: CD38 Antibody (6E12D) [NBP1-47462] - Analysis of human lung cancer (A), lymphonodus tissue (B),showing cytomembrane localization using CD38 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/CD38-Antibody-6E12D-Immunohistochemistry-Paraffin-NBP1-47462-img0004.jpg)
![Western Blot: CD38 Antibody (6E12D) [NBP1-47462] - CD38 expression in 5 B cell lymphoma cell lines. Western blot image submitted by a verified customer review.](http://images.novusbio.com/fullsize/CD38-Antibody-6E12D-Western-Blot-NBP1-47462-img0006.jpg)
![Western Blot: CD38 Antibody (6E12D) [NBP1-47462] - Analysis using CD38 mouse mouse mAb against CD38-hIgGFc transfected HEK293 cell lysate.](http://images.novusbio.com/fullsize/CD38-Antibody-6E12D-Western-Blot-NBP1-47462-img0005.jpg)
![Immunohistochemistry: CD25/IL-2R alpha Antibody (Basiliximab) - Chimeric [NBP2-75902] - Formalin fixed rat spleen slices were were stained with a NBP2-75902 at 5 ug/ml. The anti-human CD25 antibody NBP2-75902 also shows some cross-reactivity with rat in IHC.](http://images.novusbio.com/fullsize/CD25-IL-2R-alpha-Antibody-Basiliximab-Chimeric-Immunohistochemistry-NBP2-75902-img0001.jpg "Immunohistochemistry: CD25/IL-2R alpha Antibody (Basiliximab) - Chimeric [NBP2-75902] - Formalin fixed rat spleen slices were were stained with a NBP2-75902 at 5 ug/ml. The anti-human CD25 antibody NBP2-75902 also shows some cross-reactivity with rat in IHC.")
![Immunocytochemistry/Immunofluorescence: CD25/IL-2R alpha Antibody (Basiliximab) - Chimeric [NBP2-75902] - Formaldehyde-fixed rat thymus slices were stained with NBP2-75902 at 5 ug/ml and detected with a FITC-conjugated secondary antibody. Ab00188 shows weak labelling of rat cells by IF.](http://images.novusbio.com/fullsize/CD25-IL-2R-alpha-Antibody-Basiliximab-Chimeric-Immunofluorescence-NBP2-75902-img0002.jpg)
![Western Blot: CD25/IL-2R alpha Antibody (Basiliximab) - Chimeric - Azide and BSA Free [NBP2-75902] - Human thyroid cancer (lane 1), rat spleen (lane 2), mouse lymph node (lane 3), mouse thymus (lane 4) and rat small intestines (lane 5) samples were resolved on a 10% SDS PAGE gel and blots probed with NBP2-75902 at 1 ug/ml before being detected by a secondary antibody.](http://images.novusbio.com/fullsize/nbp2-75902_human-monoclonal-cd25-il-2r-alpha-antibody-basiliximab-chimeric-74202522141245.png)
![Flow Cytometry: CD25/IL-2R alpha Antibody (Basiliximab) - Chimeric [NBP2-52661] - Flow-cytometry using anti-CD25 antibody Basiliximab (NBP2-52661) Cynomolgus monkey lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Basiliximab (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD25-IL-2R-alpha-Antibody-Basiliximab-Chimeric-Flow-Cytometry-NBP2-52661-img0007.jpg "Flow Cytometry: CD25/IL-2R alpha Antibody (Basiliximab) - Chimeric [NBP2-52661] - Flow-cytometry using anti-CD25 antibody Basiliximab (NBP2-52661) Cynomolgus monkey lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Basiliximab (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Flow Cytometry: CD25/IL-2R alpha Antibody (Basiliximab) - Chimeric [NBP2-52661] - Flow-cytometry using the anti-CD25 (IL2R) research biosimilar antibody Basiliximab. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Basiliximab (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD25-IL-2R-alpha-Antibody-Basiliximab-Chimeric-Flow-Cytometry-NBP2-52661-img0005.jpg)
![Flow Cytometry: CD25/IL-2R alpha Antibody (Basiliximab) - Chimeric [NBP2-52661] - Flow-cytometry using anti-CD25 antibody Basiliximab (NBP2-52661) Rhesus monkey lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Basiliximab (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD25-IL-2R-alpha-Antibody-Basiliximab-Chimeric-Flow-Cytometry-NBP2-52661-img0006.jpg)